Member Info for MrBB

Results due next month Dave so there will be an update, if not published separately beforehand

Apart from needing to demonstrate increasing traction in the US ,we need to see increased revenues from UK & Europe .Remaining optimistic despite recent setbacks & glad to have bought a few more under 20p recently

Interims will include an Outlook Statement & if the recent theme has continued PM will remain very optimistic & will be beating the drum & let’s hope we are on target to meet /exceed FY22 expectations .
Still time for more positive news before Results !

This could be an excellent time for SD & other Directors to buy the dip ,demonstrate faith in our potential & have decent skin in the game.No reason for Sorensen , Frankham & others from TrX to buy too , if they believe in the project & our potential.PIs posting here probably account for 30% of the issued capital so not unreasonable to expect senior insiders to be buying if they believe that the delay really is temporary.
I am with Rubhard

Interim next week & Fleet will have hopefully made substantial progress,particularly since Shell deal,from which progress should have been made.Bonus if any progress reported regarding our supplying Fleet OEMs

Assuming TheoremRx raise their funds required & all progresses as expected,perhaps they will use some of their cash pile to invest in Val,as a strategic investor & ,perhaps take 10% for ,say ,$10mill,thereby strengthening our balance sheet substantially without shareholders being substantially diluted & giving T additional stake in their belief in 201 in addition to all else which Val is involved with & will be involved with.
Long shot but not beyond the realms of possibility

The "industry "clearly knows about DA & the progress being made so there must be a possibility that a strategic investor would be interested in a holding in Tern in order to gain exposure to DA & supporting a placing would provide that

PM2022-not sure what your comment regarding BC201 is based on ,but if you happen to be right ,BC201 would be gigantic as there is a massive global unmet need for a sepsis treatment & 40% of a very large number would indeed be very large

Interesting-6 blocks of sales (probably) representing over 1% of issued shares-so who bought them, as market makers would be unlikely to hold unless they expected good news inward-which we longs could certainly do with !

I would have thought that Al & Darren want to see DA gain more traction in respect of contracts won & revenues receivable before an IPO as our value will clearly be much higher once our numbers back up our rhetoric -unless another major global strategic investor wants a % at fair current value ,to ensure sufficient capital is raised to accelerate our growth plans without selling out too soon.

SBTX has been very successful in that its market value substantially exceeds ours & we have sold shares occasionally to fund our expansion without any OBTI fundraising.OPTI will benefit substantially if the latest IPO is as successful & , most importantly,the underlying business.VCT investors are awash with funds looking for homes & it will not be difficult to raise the funds required & they will be sticky investors due to the rules regarding tax relief,ensuring success of the IPO & the likelihood of a premium.
Meanwhile, the core OPTI business needs to be able to demonstrate continued traction in its many markets in order to convince The Market that it is a growth stock.

Perhaps John Kurt will recommend a purchase for 2 or 3 $bill?

40p may seem attractive right now, with uncertain Markets & our struggling to break back above 8p.Most of us have been here for many years & I want full value for my shares & would rather wait a bit longer to see our plan unfold, ie more successful RFQs, revenues ramping up ,Fleet supplying OEMs alongside retrofit to increase this division exponentially & Aviation signing contracts confirming that this will indeed be a viable third leg to our business , while also leaving the possibility of a fourth leg ( being consumer & other products).
If Mobileeye do IPO for $50BILL ( crazy numbers) I would have thought that they could be keen to acquire us in order to strengthen their hold-although I appreciate that some of our current partners would not be wild about that idea, resulting them throwing their hats in the ring to try to acquire us too.
Patience required for a little longer & Interims , Outlook & prsentations due in a couple of weeks.

Fair point Apropos1- I have looked back & cant see a Corporate reference to Japan & accept that it may be wishful thinking on my part & that of others.However,many other territories have been licensed & we are unlikely to go it alone in Japan so not unreasonable to hope for & expect a deal for that territory in the near future & , apparently, our Korean partner has a strong presence in Japan

Agreed TC & following Greg " I would hope that Greg will soon release ( Q1) news to back the "extremely bullish" view given in his latest presentation as he doesnt strike me as the sort of CEO who would express bullishness & be unable to back it up.
Our cash balances are undoubtedly running down & it will be some time before our monthly cash flow will be neutral then positive .However our monthly burn is ,hopefully,currently much less than the £2mill bandied around by the shorts & we must be close to a license deal in Japan which will produce another upfront payment,which is unlikely to be substantial but could be $3-$5mill,with view to the potential size of that prospective market.
Confirmation of growing traction,prescriptions written & revenues together with details of financing over the remainder of the year , hopefully debt rather than equity ,at this stage ,may see our SP regain some of the lost ground.
Gregg & colleagues buying meaningful numbers of shares at our current depressed levels would also help ,on every level.

Reaching full value ,whatever that may be ,assumes that PM remains committed to his plan,believes 100% in its potential & isn’t tempted to support an early offer resulting in him being a very wealthy guy (deservedly so ).
Interims & Outlook in a couple of weeks should support his very bullish recent interview & hopefully tangible news of material contract wins will soon be forthcoming

Wouldnt want to be bought too early (despite current market turmoil) & I would hope our technological lead,3 defined income streams,strong partner relations & the expectation to remain & consolidate our position as market leaders will ensure that when our time comes it will be at full value , whatever that may be ,rather than sold too early & too cheaply.

If we believe in our management ,products,partnerships client relationship & the view of industry experts we are likely to be viewed as a much stronger company once some of the contracts which PM referred to ( more bullishly than ever, just a couple of weeks ago)are won & as frustrating as it is to see our SP at these levels ( in turbulent Markets) there must be a good chance that we will regain double digits over the next few weeks & possibly subject a takeover bid in the next year or two-at which point we may be all wondering why we didnt buy more at these levels -although I appreciate that some did .I am not seduced by todays rally but if we arent subject to margin calls & our shares are owned it is still very reasonable to expect our SP to reach multiples of our current level & even Cenkos ( our Ex broker) sees us at 19.5p.This is a time for keeping our investment chins up !!

I remain long but question the commitment of Directors regarding their lack of enthusiasm for buying either more or any shares at these levels, despite the extreme bullishness of Greg in his recent presentations.Their having skin in the game (especially Greg) would put out a strong signal-the opposite of which is achieved by his inertia.

Raising loan capital should not be a problem if Greg can demonstrate growing revenues at a decent growth % over the next few months & assuming margins of,say 80% ( rather than the 90% expected once everyone is paying the full price),our monthly losses should be rapidly reducing together with cash outflows.Also scope for additional upfront licensing fees from new territories, eg Japan with a large population & unmet need due to high levels of anaemia there.